Literature DB >> 22939310

Estimating influenza latency and infectious period durations using viral excretion data.

A Cori1, A J Valleron, F Carrat, G Scalia Tomba, G Thomas, P Y Boëlle.   

Abstract

Influenza infection natural history is often described as a progression through four successive stages: Susceptible-Exposed/Latent-Infectious-Removed (SEIR). The duration of each stage determines the average generation time, the time between infection of a case and infection of his/her infector. Recently, several authors have justified somewhat arbitrary choices in stage durations by how close the resulting generation time distribution was to viral excretion over time after infection. Taking this reasoning one step further, we propose that the viral excretion profile over time can be used directly to estimate the required parameters in an SEIR model. In our approach, the latency and infectious period distributions are estimated by minimizing the Kullback-Leibler divergence between the model-based generation time probability density function and the normalized average viral excretion profile. Following this approach, we estimated that the latency and infectious period last respectively 1.6 and 1.0 days on average using excretion profiles from experimental infections. Interestingly, we find that only 5% of cases are infectious for more than 2.9 days. We also discuss the consequences of these estimates for the evaluation of the efficacy of control measures such as isolation or treatment. We estimate that, under a best-case scenario where symptoms appear at the end of the latency period, index cases must be isolated or treated at most within 16h after symptoms onset to avoid 50% of secondary cases. This study provides the first estimates of latency and infectious period for influenza based directly on viral excretion data. It provides additional evidence that isolation or treatment of cases would be effective only if adopted shortly after symptoms onset, and shows that four days of isolation may be enough to avoid most transmissions.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22939310     DOI: 10.1016/j.epidem.2012.06.001

Source DB:  PubMed          Journal:  Epidemics        ISSN: 1878-0067            Impact factor:   4.396


  17 in total

1.  Community Mitigation Guidelines to Prevent Pandemic Influenza - United States, 2017.

Authors:  Noreen Qualls; Alexandra Levitt; Neha Kanade; Narue Wright-Jegede; Stephanie Dopson; Matthew Biggerstaff; Carrie Reed; Amra Uzicanin
Journal:  MMWR Recomm Rep       Date:  2017-04-21

2.  Evidence for influenza and RSV interaction from 10 years of enhanced surveillance in Nha Trang, Vietnam, a modelling study.

Authors:  Naomi R Waterlow; Michiko Toizumi; Edwin van Leeuwen; Hien-Anh Thi Nguyen; Lay Myint-Yoshida; Rosalind M Eggo; Stefan Flasche
Journal:  PLoS Comput Biol       Date:  2022-06-24       Impact factor: 4.779

3.  Prior population immunity reduces the expected impact of CTL-inducing vaccines for pandemic influenza control.

Authors:  Kirsty J Bolton; James M McCaw; Lorena Brown; David Jackson; Katherine Kedzierska; Jodie McVernon
Journal:  PLoS One       Date:  2015-03-26       Impact factor: 3.240

4.  Inferring R0 in emerging epidemics-the effect of common population structure is small.

Authors:  Pieter Trapman; Frank Ball; Jean-Stéphane Dhersin; Viet Chi Tran; Jacco Wallinga; Tom Britton
Journal:  J R Soc Interface       Date:  2016-08       Impact factor: 4.118

5.  Epidemiological and economic impact of pandemic influenza in Chicago: Priorities for vaccine interventions.

Authors:  Nargesalsadat Dorratoltaj; Achla Marathe; Bryan L Lewis; Samarth Swarup; Stephen G Eubank; Kaja M Abbas
Journal:  PLoS Comput Biol       Date:  2017-06-01       Impact factor: 4.475

6.  The R0 package: a toolbox to estimate reproduction numbers for epidemic outbreaks.

Authors:  Thomas Obadia; Romana Haneef; Pierre-Yves Boëlle
Journal:  BMC Med Inform Decis Mak       Date:  2012-12-18       Impact factor: 2.796

7.  Effect of modelling slum populations on influenza spread in Delhi.

Authors:  Jiangzhuo Chen; Shuyu Chu; Youngyun Chungbaek; Maleq Khan; Christopher Kuhlman; Achla Marathe; Henning Mortveit; Anil Vullikanti; Dawen Xie
Journal:  BMJ Open       Date:  2016-09-29       Impact factor: 2.692

8.  Assessing the benefits of early pandemic influenza vaccine availability: a case study for Ontario, Canada.

Authors:  David Champredon; Marek Laskowski; Nathalie Charland; Seyed M Moghadas
Journal:  Sci Rep       Date:  2018-04-24       Impact factor: 4.379

9.  The reachability of contagion in temporal contact networks: how disease latency can exploit the rhythm of human behavior.

Authors:  Ewan Colman; Kristen Spies; Shweta Bansal
Journal:  BMC Infect Dis       Date:  2018-05-15       Impact factor: 3.090

10.  Management and control of communicable diseases in schools and other child care settings: systematic review on the incubation period and period of infectiousness.

Authors:  Ida Czumbel; Chantal Quinten; Pierluigi Lopalco; Jan C Semenza
Journal:  BMC Infect Dis       Date:  2018-05-02       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.